BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

446 related articles for article (PubMed ID: 7556810)

  • 41. Increased prevalence of microvascular complications in type 2 diabetes patients with the metabolic syndrome.
    Abdul-Ghani M; Nawaf G; Nawaf F; Itzhak B; Minuchin O; Vardi P
    Isr Med Assoc J; 2006 Jun; 8(6):378-82. PubMed ID: 16833164
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Early rheological and microcirculatory changes in children with type I diabetes mellitus.
    Koscielny J; Latza R; Wolf S; Kiesewetter H; Jung F
    Clin Hemorheol Microcirc; 1998 Oct; 19(2):139-50. PubMed ID: 9849927
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Mean platelet volume in patients with type 2 diabetes mellitus.
    Papanas N; Symeonidis G; Maltezos E; Mavridis G; Karavageli E; Vosnakidis T; Lakasas G
    Platelets; 2004 Dec; 15(8):475-8. PubMed ID: 15763888
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Hemorheological disorders during ischemic brain infarcts in patients with and without diabetes mellitus.
    Momtselidze N; Mantskava M; Mchedlishvili G
    Clin Hemorheol Microcirc; 2006; 35(1-2):261-4. PubMed ID: 16899939
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Plasma fibronectin in diabetic retinopathy and macroangiopathy.
    Seghieri G; Bartolomei G; De Giorgio LA
    Diabete Metab; 1986 Aug; 12(4):186-90. PubMed ID: 3770274
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effects of long-term treatment (4 years) with pentoxifylline on haemorheological changes and vascular complications in diabetic patients.
    Ferrari E; Fioravanti M; Patti AL; Viola C; Solerte SB
    Pharmatherapeutica; 1987; 5(1):26-39. PubMed ID: 3602021
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A study of plasma C4 concentration and its possible association with microvascular complications in type I (insulin dependent) and type II (non-insulin dependent) diabetes.
    Arora S; Gauri LA; Saxena HC
    J Assoc Physicians India; 1988 Jul; 36(7):425-7. PubMed ID: 3204087
    [No Abstract]   [Full Text] [Related]  

  • 48. [Fibrinogen-fibrin degradation products in diabetes mellitus].
    Alakhverdian R; Koev D
    Vutr Boles; 1987; 26(6):72-5. PubMed ID: 3125689
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Coagulation profile in diabetes and its association with diabetic microvascular complications.
    Madan R; Gupt B; Saluja S; Kansra UC; Tripathi BK; Guliani BP
    J Assoc Physicians India; 2010 Aug; 58():481-4. PubMed ID: 21189694
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Blood viscosity in diabetes mellitus (evaluation on the basis of high shear rates)].
    Sarno A; Catania A; Capobianco D; Frazzetta F; Francavilla G; Caimi G
    Ric Clin Lab; 1983; 13 Suppl 3():367-70. PubMed ID: 6673015
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Blood viscosity and erythrocyte filterability: their evaluation in diabetes mellitus.
    Caimi G
    Horm Metab Res; 1983 Oct; 15(10):467-70. PubMed ID: 6642407
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Abnormal hemorheology in diabetes mellitus.
    Barnes A; Locke P; Dormandy J; Dormandy T
    Bibl Anat; 1977; (16 Pt 2):428-9. PubMed ID: 603576
    [No Abstract]   [Full Text] [Related]  

  • 53. [Basal blood level of thyroxine in diabetes mellitus patients].
    Vakov L; Zakharieva B
    Vutr Boles; 1987; 26(1):60-5. PubMed ID: 3590731
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Increased plasma endothelin levels in patients with insulin-dependent diabetes mellitus and end-stage vascular complications.
    Kirilov G; Dakovska L; Borisova AM; Krivoshiev S; Nentchev N
    Horm Metab Res; 1994 Feb; 26(2):119-20. PubMed ID: 8200615
    [No Abstract]   [Full Text] [Related]  

  • 55. Activity of Daflon 500 mg on the hemorheological disorders in diabetes.
    Lacombe C; Lelievre JC; Bucherer C; Grimaldi A
    Int Angiol; 1989; 8(4 Suppl):45-8. PubMed ID: 2632648
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Basal blood level of thyrotropic hormone in diabetes mellitus patients].
    Vakov L; Milanov S
    Vutr Boles; 1984; 23(2):92-7. PubMed ID: 6741116
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Red-cell aggregation and red-cell deformability in diabetes.
    Schmid-Schönbein H; Volger E
    Diabetes; 1976; 25(2 SUPPL):897-902. PubMed ID: 971793
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Vitamin C metabolites and microangiopathy in diabetes mellitus.
    Jennings PE; Chirico S; Jones AF; Lunec J; Barnett AH
    Diabetes Res; 1987 Nov; 6(3):151-4. PubMed ID: 3436115
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Rheological and microvascular parameters in diabetic peripheral neuropathy.
    Young MJ; Bennett JL; Liderth SA; Veves A; Boulton AJ; Douglas JT
    Clin Sci (Lond); 1996 Mar; 90(3):183-7. PubMed ID: 8777823
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Hemorheologic studies for evaluating microcirculation in patients with peripheral arterial circulatory disorders and diabetes mellitus].
    Sternitzky R; Hänsgen K; Podhaisky H; Frank I; Klare M; Preuss EG
    Z Gesamte Inn Med; 1986 Oct; 41(19):539-42. PubMed ID: 3811440
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.